St. Jude Medical issues pain management device recall; Mazor Robotics seeks $15M private equity placement;

 @FierceMedDev: Given Imaging's rough stock slump last week was a major overreaction, at least one analyst is saying--via BloombergMore | Follow @FierceMedDev

 @MarkHFierce: MIT tech helped U.K. scientists discover a new class of polymers that could coat med devices and help reduce bacteria. Story | Follow @MarkHFierce

 @DamianFierce: Medtronic is looking to get a foothold in China with some M&A. More | Follow @DamianFierce

> The FDA's decision to reduce indications for Stryker's ($SYK) Wingspan brain stent in the wake of safety concerns is yet another example of how flawed the agency's approval process for medical devices continues to be, the consumer group Public Citizen argues. Story

> St. Jude Medical ($STJ) is recalling some of its Eon and Eon Mini pain management implant devices because of potentially faulty batteries. More

> Cook Medical released previously undisclosed three-year data that shows its paclitaxel-eluting peripheral vascular stent generated 83% of freedom from target lesion revascularization, compared to angioplasty and bare metal stenting after three years. Release

> Expect more medical device liability lawsuits in the wake of the New Jersey Supreme Court's decision not to dismiss a complaint against a Johnson & Johnson ($JNJ) subsidiary's coronary stent, an attorney predicts. Story

> In Europe, Roche ($RHHBY) is launching a new IVD version of its MagNA Pure 96 system for automated preparation of samples for diagnostic purposes. Release

> Mazor Robotics, a developer of surgical robots and other related products, plans a private equity placement of up to $15 million. Release

Biotech News

 @FierceBiotech: FDA taps data-mining tech for drug safety research. More | Follow @FierceBiotech

 @JohnCFierce: Elcelyx sheds stealth status, adds venture bucks as it seeks obesity pacts. More | Follow @JohnCFierce

 @RyanMFierce: Mount Sinai's Eric Schadt reflects on first year at $100 million genomics center. More | Follow @RyanMFierce

> Both low and OK'd doses of Acorda's Ampyra fall shy of key endpoint. Article

> Elan stokes buyout buzz with plan for $130M R&D spinout. News

Pharma News

 @FiercePharma: "Unnerved" by "weakness in the base business," Jefferies downgrades Glaxo to "hold." Next year = better, firm says. More | Follow @FiercePharma

> Sun finally nabs Taro with $600M deal. News

> Icahn accuses Forest of hidden 'poison pill.' More

> It's official: Pfizer files its animal-health IPO. Report

Biotech IT News

> BioClinica accelerates spending to support eClinical surge. Article

> Sanofi trains social-media eye on diabetics. Story

> U.K. scientists tap into e-health research with Centers of Excellence. More

CRO News

> Theorem and Gallus team up to offer CRO, CMO services. Article

> Charles River bolsters IT spending to stand out in CRO crowd. Story

> Fuji Pharma jumps into CMO game with $53.4M plant buy. More

And Finally... Berlin Heart's Excor pediatric ventricular assist device is a finalist for the 2012 Prix Galien Award for best medical technology product. Release

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.